Recent studies have shown that the expression of FasL in the eye is important to the maintenance of immune privilege. FasL induces apoptosis in Fas+ lymphoid cells that attempt to pass the blood-ocular barrier and invade the eye. FasL is clearly one of the important mediators of immune privilege that acts in concert with other factors found constitutively in the eye to preserve vision. Although a number of studies have examined the expression of FasL in immune privileged sites, insight into how expression is regulated has been lacking. This has hampered elucidation of important mechanisms much beyond the phenomenological stage, as function is often inferred from RT-PCR data, in vitro cell lines, or unreliable antibodies. In this application, we will continue to explore the regulation of FasL expression using novel mouse strains that will give us a unique look at FasL and the eye.
In specific aim 1, we will use recently developed mouse strains to explore FasL expression in the eye. These strains include a FasL promoter-luciferase reporter strain, a FasL-eYFP """"""""knock-in"""""""" strain, and a FasL-flox strain.
In aim 2, we will explore the apparent resistance of activated T-cells to killing by ocular FasL. These studies will examine T cells obtained from TCR -transgenic mice, as well as those activated to an ocular autoantigen.
Aim 3 will further define the role of TRAIL (for TNF-related apoptosis inducing ligand) in the eye. Preliminary studies suggest that it may protect the eye from invasion by tumor cells.
In aim 4, we will continue to explore the role of apoptosis and apoptotic cells in regulation of the immune response. Here, we will use a unique approach to define regulatory T cells and identify antigen-presenting cells involved in peripheral tolerance. We believe that the completion of these aims in this application will permit us to better understand important mechanisms that protect the eye and maintain the visual axis.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY006765-19
Application #
6858532
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Shen, Grace L
Project Start
1988-04-01
Project End
2007-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
19
Fiscal Year
2005
Total Cost
$382,500
Indirect Cost
Name
Washington University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ferguson, Thomas A; Green, Douglas R (2014) Autophagy and phagocytosis converge for better vision. Autophagy 10:165-7
Zhao, Hui; Roychoudhury, Jayeeta; Doggett, Teresa A et al. (2013) Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration. Invest Ophthalmol Vis Sci 54:5321-31
Mattapallil, Mary J; Wawrousek, Eric F; Chan, Chi-Chao et al. (2012) The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci 53:2921-7
Pillai, Meenu R; Collison, Lauren W; Wang, Xiaohua et al. (2011) The plasticity of regulatory T cell function. J Immunol 187:4987-97
Griffith, Thomas S; Ferguson, Thomas A (2011) Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 35:456-66
Ferguson, Thomas A; Choi, Jayoung; Green, Douglas R (2011) Armed response: how dying cells influence T-cell functions. Immunol Rev 241:77-88
Griffith, Thomas S; Brincks, Erik L; Gurung, Prajwal et al. (2011) Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. J Immunol 186:791-8
Gurung, Prajwal; Kucaba, Tamara A; Schoenberger, Stephen P et al. (2010) TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion. J Leukoc Biol 88:1217-25
Unsinger, Jacqueline; Kazama, Hirotaka; McDonough, Jacqueline S et al. (2010) Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J Immunol 184:6766-72
Roychoudhury, Jayeeta; Herndon, John M; Yin, Jiyi et al. (2010) Targeting immune privilege to prevent pathogenic neovascularization. Invest Ophthalmol Vis Sci 51:3560-6

Showing the most recent 10 out of 19 publications